Comparison Chart Prothena Corporation plc
Equities
PRTA
IE00B91XRN20
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.800 USD | +2.08% |
|
-6.46% | +3.04% |
| 05-07 | Prothena Corporation plc Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-27 | Prothena Says Novo Nordisk Gets FDA Fast Track Designation for Coramitug in ATTR-CM | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTHENA CORPORATION PLC | Bio Therapeutic Drugs | +2.29% | -6.46% | +3.04% | +42.92% | -57.18% | 503M |  |  |  |
- Stock Market
- Equities
- PRTA Stock
- Charts Prothena Corporation plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition